Bok S H, Lee S H, Park Y B, Bae K H, Son K H, Jeong T S, Choi M S
Korea Institute of Bioscience and Biotechnology, KIST, Yusong, Taejon, 305-333, Korea.
J Nutr. 1999 Jun;129(6):1182-5. doi: 10.1093/jn/129.6.1182.
The cholesterol-lowering effects of tangerine peel extract and a mixture of two citrus flavonoids were tested. Male rats were fed a 1 g/100 g high-cholesterol diet for 42 d with supplements of either tangerine-peel extract or a mixture of naringin and hesperidin (0.5 g/100 g) to study the effects of plasma and hepatic lipids, hepatic enzyme activities, and the excretion of fecal neutral sterols. Both the tangerine-peel extract and mixture of two flavonoids significantly lowered the levels (mean +/- SE) of plasma (2.44 +/- 0. 59 and 2.42 +/- 0.31 mmol/L, vs. 3.80 +/- 0.28 mmol/L, P < 0.05), hepatic cholesterol (0.143 +/- 0.017 and 0.131 +/- 0.010 mmol/g vs. 0.181 +/- 0.003 mmol/g, P < 0.05), and hepatic triglycerides (0.069 +/- 0.007 and 0.075 +/- 0.006 mmol/g vs. 0.095 +/- 0.002 mmol/g, P < 0.05) compared to those of the control. The 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase (1565.0 +/- 106. 0 pmol. min-1. mg protein-1 and 1783.0 +/- 282 pmol. min-1. mg protein-1 vs. 2487.0 +/- 210.0 pmol. min-1. mg protein-1, P < 0.05) and acyl CoA: cholesterol O-acyltransferase (ACAT) activities (548.0 +/- 65.0 and 615.0 +/- 80.0 pmol. min-1. mg protein-1 vs. 806.0 +/- 105.0 pmol. min-1. mg protein-1, P < 0.05) were significantly lower in the experimental groups than in the control. These supplements also substantially reduced the excretion of fecal neutral sterols compared to the control (211.1 +/- 26.7 and 208.2 +/- 31.6 mg/d vs. 521.9 +/- 53.9 mg/d). The inhibition of HMG-CoA reductase and ACAT activities resulting from the supplementation of either tangerine-peel extract or a combination of its bioflavonoids could account for the decrease in fecal neutral sterol that appears to compensate for the decreased cholesterol biosynthesis in the liver.
测试了陈皮提取物和两种柑橘类黄酮混合物的降胆固醇效果。雄性大鼠喂食1 g/100 g高胆固醇饮食42天,并补充陈皮提取物或柚皮苷和橙皮苷的混合物(0.5 g/100 g),以研究血浆和肝脏脂质、肝脏酶活性以及粪便中性固醇排泄的影响。与对照组相比,陈皮提取物和两种黄酮类化合物的混合物均显著降低了血浆(2.44±0.59和2.42±0.31 mmol/L,vs. 3.80±0.28 mmol/L,P<0.05)、肝脏胆固醇(0.143±0.017和0.131±0.010 mmol/g vs. 0.181±0.003 mmol/g,P<0.05)和肝脏甘油三酯(0.069±0.007和0.075±0.006 mmol/g vs. 0.095±0.002 mmol/g,P<0.05)的水平。与对照组相比,实验组的3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶(1565.0±106.0 pmol·min-1·mg蛋白-1和1783.0±282 pmol·min-1·mg蛋白-1 vs. 2487.0±210.0 pmol·min-1·mg蛋白-1,P<0.05)和酰基辅酶A:胆固醇O-酰基转移酶(ACAT)活性(548.0±65.0和615.0±80.0 pmol·min-1·mg蛋白-1 vs. 806.0±105.0 pmol·min-1·mg蛋白-1,P<0.05)显著降低。与对照组相比,这些补充剂还显著减少了粪便中性固醇的排泄(211.1±26.7和208.2±31.6 mg/d vs. 521.9±53.9 mg/d)。补充陈皮提取物或其生物类黄酮组合导致的HMG-CoA还原酶和ACAT活性的抑制可能是粪便中性固醇减少的原因,这似乎补偿了肝脏中胆固醇生物合成的减少。